Strensiq Receives Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia
July 06, 2015 at 06:03 AM EDT
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) approved the ...